FeTMPyP a peroxynitrite decomposition catalyst ameliorated functional and behavioral deficits in chronic constriction injury induced neuropathic pain in rats

References

• Woolf CJ, Mannion RJ. Neuropathic pain: aetiology, symptoms, mechanisms, and management. Lancet. 1999;353(9168):1959–1964.
   PubMed Web of Science ®Google Scholar
• Colloca L, Ludman T, Bouhassira D, et al. Neuropathic pain. Nat Rev Dis Primers. 2017;3:17002.
   PubMed Web of Science ®Google Scholar
• Li J, Wang G, Weng Y, et al. Netrin-1 contributes to peripheral nerve injury induced neuropathic pain via regulating phosphatidylinositol 4-kinase IIa in the spinal cord dorsal horn in mice. Neurosci Lett. 2020;735:135161.
   PubMed Web of Science ®Google Scholar
• Shan W, Liao X, Tang Y, et al. Dexmedetomidine alleviates inflammation in neuropathic pain by suppressing NLRP3 via Nrf2 activation. Exp Ther Med. 2021;22(4):1046.
   PubMed Web of Science ®Google Scholar
• Vinik AI, Strotmeyer ES, Nakave AA, et al. Diabetic neuropathy in older adults. Clin Geriatr Med. 2008;24(3):407–435, v.
   PubMed Web of Science ®Google Scholar
• Kalvala AK, Kumar R, Sherkhane B, et al. Bardoxolone methyl ameliorates hyperglycemia induced mitochondrial dysfunction by activating the keap1-Nrf2-ARE pathway in experimental diabetic neuropathy. Mol Neurobiol. 2020;57(8):3616–3631.
   PubMed Web of Science ®Google Scholar
• d'Avila JC, Lam TI, Bingham D, et al. Microglial activation induced by brain trauma is suppressed by post-injury treatment with a PARP inhibitor. J Neuroinflammation. 2012;9:31.
   PubMed Web of Science ®Google Scholar
• Komirishetty P, Areti A, Yerra VG, et al. PARP inhibition attenuates neuroinflammation and oxidative stress in chronic constriction injury induced peripheral neuropathy. Life Sci. 2016;150:50–60.
   PubMed Web of Science ®Google Scholar
• Sandireddy R, Yerra VG, Areti A, et al. Neuroinflammation and oxidative stress in diabetic neuropathy: futuristic strategies based on these targets. Int J Endocrinol. 2014;2014:674987.
   PubMed Web of Science ®Google Scholar
• Negi G, Kumar A, Sharma SS. Melatonin modulates neuroinflammation and oxidative stress in experimental diabetic neuropathy: effects on NF-κB and Nrf2 Cascades. J Pineal Res. 2011;50(2):124–131.
   PubMed Web of Science ®Google Scholar
• Kumar A, Sharma SS. NF-kappaB inhibitory action of resveratrol: a probable mechanism of neuroprotection in experimental diabetic neuropathy. Biochem Biophys Res Commun. 2010;394(2):360–365.
   PubMed Web of Science ®Google Scholar
• Luo X, Kraus WL. On PAR with PARP: cellular stress signaling through poly(ADP-ribose) and PARP-1. Genes Dev. 2012;26(5):417–432.
   PubMed Web of Science ®Google Scholar
• Du L, Zhang X, Han YY, et al. Intra-mitochondrial poly(ADP-ribosylation) contributes to NAD + depletion and cell death induced by oxidative stress. J Biol Chem. 2003;278(20):18426–18433.
   PubMed Web of Science ®Google Scholar
• Nangle MR, Cotter MA, Cameron NE. Effects of the peroxynitrite decomposition catalyst, FeTMPyP, on function of corpus cavernosum from diabetic mice. Eur J Pharmacol. 2004;502(1–2):143–148.
   PubMed Web of Science ®Google Scholar
• Beckman JS, Chen J, Crow JP, et al. Reactions of nitric oxide, superoxide and peroxynitrite with superoxide dismutase in neurodegeneration. Prog Brain Res. 1994;103:371–380.
   PubMed Web of Science ®Google Scholar
• Thiyagarajan M, Kaul CL, Sharma SS. Neuroprotective efficacy and therapeutic time window of peroxynitrite decomposition catalysts in focal cerebral ischemia in rats. Br J Pharmacol. 2004;142(5):899–911.
   PubMed Web of Science ®Google Scholar
• Jangra A, Datusalia AK, Sharma SS. Reversal of neurobehavioral and neurochemical alterations in STZ-induced diabetic rats by FeTMPyP, a peroxynitrite decomposition catalyst and 1,5-Isoquinolinediol a poly(ADP-ribose) polymerase inhibitor. Neurol Res. 2014;36(7):619–626.
   PubMed Web of Science ®Google Scholar
• Palomares SM, Gardner-Morse I, Sweet JG, et al. Peroxynitrite decomposition with FeTMPyP improves plasma-induced vascular dysfunction and infarction during mild but not severe hyperglycemic stroke. J Cereb Blood Flow Metab. 2012;32(6):1035–1045.
   PubMed Web of Science ®Google Scholar
• Lord CJ, Ashworth A. Targeted therapy for cancer using PARP inhibitors. Curr Opin Pharmacol. 2008;8(4):363–369.
   PubMed Web of Science ®Google Scholar
• Garcia Soriano F, Virág L, Jagtap P, et al. Diabetic endothelial dysfunction: the role of poly(ADP-ribose) polymerase activation. Nat Med. 2001;7(1):108–113.
   PubMed Web of Science ®Google Scholar
• Komirishetty P, Areti A, Gogoi R, et al. Poly(ADP-ribose) polymerase inhibition reveals a potential mechanism to promote neuroprotection and treat neuropathic pain. Neural Regen Res. 2016;11(10):1545–1548.
   PubMed Web of Science ®Google Scholar
• Komirishetty P, Areti A, Sistla R, et al. Morin mitigates chronic constriction injury (CCI)-induced peripheral neuropathy by inhibiting oxidative stress induced PARP over-Activation and neuroinflammation. Neurochem Res. 2016;41(8):2029–2042.
   PubMed Web of Science ®Google Scholar
• Bennett GJ, Xie YK. A peripheral mononeuropathy in rat that produces disorders of pain sensation like those seen in man. Pain. 1988;33(1):87–107.
   PubMed Web of Science ®Google Scholar
• Bain JR, Mackinnon SE, Hunter DA. Functional evaluation of complete sciatic, peroneal, and posterior tibial nerve lesions in the rat. Plast Reconstr Surg. 1989;83(1):129–138.
   PubMed Web of Science ®Google Scholar
• Huang C, Hu ZP, Long H, et al. Attenuation of mechanical but not thermal hyperalgesia by electroacupuncture with the involvement of opioids in rat model of chronic inflammatory pain. Brain Res Bull. 2004;63(2):99–103.
   PubMed Web of Science ®Google Scholar
• Gradl G, Herlyn P, Finke B, et al. A pan-caspase inhibitor reduces myocyte apoptosis and neuropathic pain in rats with chronic constriction injury of the sciatic nerve. Anesth Analg. 2013;116(1):216–223.
   PubMed Web of Science ®Google Scholar
• Flatters SJ, Bennett GJ. Ethosuximide reverses paclitaxel- and vincristine-induced painful peripheral neuropathy. Pain. 2004;109(1–2):150–161.
   PubMed Web of Science ®Google Scholar
• Jaggi AS, Singh N. Differential effect of spironolactone in chronic constriction injury and vincristine-induced neuropathic pain in rats. Eur J Pharmacol. 2010;648(1–3):102–109.
   PubMed Web of Science ®Google Scholar
• Joshi RP, Negi G, Kumar A, et al. SNEDDS curcumin formulation leads to enhanced protection from pain and functional deficits associated with diabetic neuropathy: an insight into its mechanism for neuroprotection. Nanomedicine. 2013;9(6):776–785.
   PubMed Web of Science ®Google Scholar
• Arruri VK, Gundu C, Kalvala AK, et al. Carvacrol abates NLRP3 inflammasome activation by augmenting Keap1/nrf-2/p62 directed autophagy and mitochondrial quality control in neuropathic pain. Nutr Neurosci. 2021:1–16. [Online ahead of print].
   PubMed Web of Science ®Google Scholar
• Kumar A, Negi G, Sharma SS. JSH-23 targets nuclear factor-kappa B and reverses various deficits in experimental diabetic neuropathy: effect on neuroinflammation and antioxidant defence. Diabetes Obes Metab. 2011;13(8):750–758.
   PubMed Web of Science ®Google Scholar
• Khuankaew C, Sawaddiruk P, Surinkaew P, et al. Possible roles of mitochondrial dysfunction in neuropathy. Int J Neurosci. 2021;131(10):1019–1041.
   PubMed Web of Science ®Google Scholar
• Dai CQ, Guo Y, Chu XY. Neuropathic pain: the dysfunction of Drp1, mitochondria, and ROS homeostasis. Neurotox Res. 2020;38(3):553–563.
   PubMed Web of Science ®Google Scholar
• Chogtu B, Bairy KL, Smitha D, et al. Comparison of the efficacy of carbamazepine, gabapentin and lamotrigine for neuropathic pain in rats. Indian J Pharmacol. 2011;43(5):596–598.
   PubMed Web of Science ®Google Scholar
• Veves A, Backonja M, Malik RA. Painful diabetic neuropathy: epidemiology, natural history, early diagnosis, and treatment options. Pain Med. 2008;9(6):660–674.
   PubMed Web of Science ®Google Scholar
• Nadig PD, Revankar RR, Dethe SM, et al. Effect of tinospora cordifolia on experimental diabetic neuropathy. Indian J Pharmacol. 2012;44(5):580–583.
   PubMed Web of Science ®Google Scholar
• Ellis RJ, Toperoff W, Vaida F, et al. Smoked medicinal cannabis for neuropathic pain in HIV: a randomized, crossover clinical trial. Neuropsychopharmacology. 2009;34(3):672–680.
   PubMed Web of Science ®Google Scholar
• Raicher I, Stump PR, Baccarelli R, et al. Neuropathic pain in leprosy. Clin Dermatol. 2016;34(1):59–65.
   PubMed Web of Science ®Google Scholar
• Martinez V, Üçeyler N, Ben Ammar S, et al. Clinical, histological, and biochemical predictors of postsurgical neuropathic pain. Pain. 2015;156(11):2390–2398.
   PubMed Web of Science ®Google Scholar
• Chaitanya GV, Steven AJ, Babu PP. PARP-1 cleavage fragments: signatures of cell-death proteases in neurodegeneration. Cell Commun Signal. 2010;8:31.
   PubMed Web of Science ®Google Scholar
• Sharma SS, Kumar A, Arora M, et al. Neuroprotective potential of combination of resveratrol and 4-amino 1,8 naphthalimide in experimental diabetic neuropathy: focus on functional, sensorimotor and biochemical changes. Free Radic Res. 2009;43(4):400–408.
   PubMed Web of Science ®Google Scholar
• Little JW, Chen Z, Doyle T, et al. Supraspinal peroxynitrite modulates pain signaling by suppressing the endogenous opioid pathway. J Neurosci. 2012;32(32):10797–10808.
   PubMed Web of Science ®Google Scholar
• Costa B, Trovato AE, Colleoni M, et al. Effect of the cannabinoid CB1 receptor antagonist, SR141716, on nociceptive response and nerve demyelination in rodents with chronic constriction injury of the sciatic nerve. Pain. 2005;116(1–2):52–61.
   PubMed Web of Science ®Google Scholar
• Attal N, Jazat F, Kayser V, et al. Further evidence for 'pain-related' behaviours in a model of unilateral peripheral mononeuropathy. Pain. 1990;41(2):235–251.
   PubMed Web of Science ®Google Scholar
• Na HS, Yoon YW, Chung JM. Both motor and sensory abnormalities contribute to changes in foot posture in an experimental rat neuropathic model. Pain. 1996;67(1):173–178.
   PubMed Web of Science ®Google Scholar
• Obrosova IG, Drel VR, Pacher P, et al. Oxidative-nitrosative stress and poly(ADP-ribose) polymerase (PARP) activation in experimental diabetic neuropathy: the relation is revisited. Diabetes. 2005;54(12):3435–3441.
   PubMed Web of Science ®Google Scholar
• Stavniichuk R, Shevalye H, Lupachyk S, et al. Peroxynitrite and protein nitration in the pathogenesis of diabetic peripheral neuropathy. Diabetes Metab Res Rev. 2014;30(8):669–678.
   PubMed Web of Science ®Google Scholar
• Khuankaew C, Apaijai N, Sawaddiruk P, et al. Effect of coenzyme Q10 on mitochondrial respiratory proteins in trigeminal neuralgia. Free Radic Res. 2018;52(4):415–425.
   PubMed Web of Science ®Google Scholar
• Arruri VK, Gundu C, Khan I, et al. PARP overactivation in neurological disorders. Mol Biol Rep. 2021;48(3):2833–2841.
   PubMed Web of Science ®Google Scholar
• Palazzo L, Mikolčević P, Mikoč A, et al. ADP-ribosylation signalling and human disease. Open Biol. 2019;9(4):190041.
   PubMed Web of Science ®Google Scholar
• Obrosova IG, Xu W, Lyzogubov VV, et al. PARP inhibition or gene deficiency counteracts intraepidermal nerve fiber loss and neuropathic pain in advanced diabetic neuropathy. Free Radic Biol Med. 2008;44(6):972–981.
   PubMed Web of Science ®Google Scholar
• Fink B, Coppey L, Davidson E, et al. Effect of mitoquinone (Mito-Q) on neuropathic endpoints in an obese and type 2 diabetic rat model. Free Radic Res. 2020;54(5):311–318.
   PubMed Web of Science ®Google Scholar